November 13, 2015
Tyrosinemia: Ultra-Rare, Life-Threatening, and Treatable
If the odds were 1 in 100,000 you were that one, well…. most times you’d consider yourself lucky. But what if you were 1 in 100,000 born with one of the rarest, most deadly diseases known to medicine? Those are the odds with Hereditary Tyrosinemia Type 1, or HT-1 – odds no one wants to face. And even though it only affects a few hundred people in the entire world, don’t think YOU don’t need to know about this mysterious genetic disorder. Listen as the Miller family tells a harrowing story of multiple diagnoses, all while the clock was ticking against the life of their newborn son – to the point where little Evan Miller was given less than 48 hours to live. Then hear Dr. Muge Gucsavas Calikoglu Associate Professor of Pediatrics University of North Carolina Healthcare… explain what symptoms to look for, what to do about them, and what treatment options are available to today’s courageous young HT-1 patients. Find out what advocates and experts are doing to make sure EVERY State has the critical Succinylac
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.